Jefferies Adjusts Viatris Price Target
Investment firm Jefferies has raised its price target for Viatris Inc. from $20.00 to $22.00.
Stocks · News reference
Deal Dispatch: Uber Buys ezCater For $2.3B, Skydance Takes Over Warner Bros., True Food Kitchen Bankruptcy
Major M&A deals this week include Viatris buys Pacira BioSciences, TowneBank acquires blueharbor, Energy Transfer buys Vacquero Midstream.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wall Street Analysts Update McKesson Price Targets
Multiple major financial institutions have updated their ratings and price targets for McKesson Corporation, with targets now ranging between $1,200 and $1,260.
Caribou Biosciences Reports Third Quarter 2026 Financial Results
Caribou Biosciences reported its financial results for the third quarter of 2026, highlighting a net loss of $26.6 million and ongoing strategic restructuring efforts.
McKesson and Clayton, Dubilier & Rice Secure Financing for Option Care Health Acquisition
McKesson Corporation and private equity firm Clayton, Dubilier & Rice have engaged Wall Street banks to arrange $3.1 billion in financing for their acquisition of Option Care Health.
McKesson and Clayton, Dubilier & Rice Secure $3.1 Billion Financing for Option Care Health Acquisition
McKesson Corporation and private equity firm Clayton, Dubilier & Rice have engaged Wall Street banks to arrange $3.1 billion in financing to support their acquisition of Option Care Health.
UBS Maintains Buy on McKesson, Raises Price Target to $1250